[go: up one dir, main page]

IT1109133B - Composizione anti cancro - Google Patents

Composizione anti cancro

Info

Publication number
IT1109133B
IT1109133B IT68220/78A IT6822078A IT1109133B IT 1109133 B IT1109133 B IT 1109133B IT 68220/78 A IT68220/78 A IT 68220/78A IT 6822078 A IT6822078 A IT 6822078A IT 1109133 B IT1109133 B IT 1109133B
Authority
IT
Italy
Prior art keywords
cancer composition
cancer
composition
Prior art date
Application number
IT68220/78A
Other languages
English (en)
Other versions
IT7868220A0 (it
Inventor
Fujii Setsuro
Unemi Norio
Takeda Setsuo
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11867814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1109133(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of IT7868220A0 publication Critical patent/IT7868220A0/it
Application granted granted Critical
Publication of IT1109133B publication Critical patent/IT1109133B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT68220/78A 1978-02-10 1978-05-26 Composizione anti cancro IT1109133B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53014676A JPS5953885B2 (ja) 1978-02-10 1978-02-10 抗腫瘍剤組成物

Publications (2)

Publication Number Publication Date
IT7868220A0 IT7868220A0 (it) 1978-05-26
IT1109133B true IT1109133B (it) 1985-12-16

Family

ID=11867814

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68220/78A IT1109133B (it) 1978-02-10 1978-05-26 Composizione anti cancro

Country Status (3)

Country Link
JP (1) JPS5953885B2 (it)
CH (1) CH639272A5 (it)
IT (1) IT1109133B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141506T1 (de) * 1990-09-07 1996-09-15 Taiho Pharmaceutical Co Ltd Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53124624A (en) * 1977-04-05 1978-10-31 Taiho Pharmaceutical Co Ltd Antiitumor agent

Also Published As

Publication number Publication date
JPS5953885B2 (ja) 1984-12-27
JPS54107527A (en) 1979-08-23
CH639272A5 (en) 1983-11-15
IT7868220A0 (it) 1978-05-26

Similar Documents

Publication Publication Date Title
FI793071A (fi) Heterocykliska kompositioner
BE880838A (fr) Composition thermochrome
DE2962442D1 (de) Compositions photodurcissables
AT369262B (de) Shampoozusammensetzung
IT1193808B (it) Composizioni termogeniche
BR8004998A (pt) Composicao desondorante
IT1174662B (it) Composizioni anti-coccidiosi
FI793369A (fi) Kompositioner
BR7900746A (pt) Composicao fotopolimerizavel
BR8004999A (pt) Composicao desordorante
FI793458A (fi) Kompositioner
SE7910139L (sv) Mjukmedelshaltiga detergentkompositioner
DE2960270D1 (de) Photocurable compositions
RO78883A (ro) Compozitie cromogena
RO84391A (ro) Compozitie erbicida
MX150774A (es) Composicion polimerizable mejorada
RO80247A (ro) Compozitie acaricida
BR7904031A (pt) Composicao tenso-ativa
RO79731A (ro) Compozitie erbicida
IT1119283B (it) Composizione anti cancro
SE7900413L (sv) Etbar komposition
IT1098212B (it) Antracioline antitumorali sostituite
AR218540A1 (es) Composicion dentifrica mejorada
RO78398A (ro) Compozitie erbicida sinergetica
RO82489A (ro) Compozitie erbicida

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530